UnknownNot Applicable

Ureteral Reimplantation for the Treatment of Extrinsic Malignant Ureteral Obstruction

50 participantsStarted 2014-06

Plain-language summary

A single center single arm prospective study, assessing the outcome of ureteral re-implantation for malignant ureteral obstruction.

Age range18 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

✓. Adult patient, older than 18 years of age.
✓. Patient with malignant ureteral obstruction diagnosed by creatinine elevation with evidence of ureteral obstruction on imaging.
✓. Patient is scheduled for ureteral reimplantation due to extrinsic malignant ureteral obstruction.
✓. American Society of Anesthesiologist score ≤3, enabling the patient to undergo surgery.

✕. WHO performance status 0-2
✕. The patient is willing and able to read, understand and sign the study specific informed consent form
✕. Patients who underwent urinary diversion other than percutaneous nephrostomy or retrograde ureteral stenting prior to the planned treatment.
✕. Patients unable to sign an informed consent for or unwilling to undergo so.
✕. Life expectancy of less than 6 months, as defined according to the criteria by Ishioka et al. and predicted in the presence of:

Ureteral patency - 6 months

Timeframe: 6 months following the operation

NCT IDNCT02160652

SponsorRabin Medical Center

Sponsor typeOTHER

Study typeOBSERVATIONAL

Primary completion2018-06